Tissue Array
Log In | My Account | Cart (0 items) - $0.00
US Biomax, Inc.
 

BC00016

Multiple organ diseased tissues, 54 cases/54 cores, replaced by MC541 tissue arrays

Microarray Panel:Multiple organ diseased tissue microarray, single core per case, 54 cases of 18 kinds of organs carcinoma (brain, esophagus, stomach, liver, colon, rectum, lung, bladder, heart, kidney and so on)
Cores:54
Cases:54
Layout:9 cols × 6 rows
Core Diameter:1.5 mm
Thickness:5 µm
Quality Control:Anti-Cytokeratin (CK) confirmed
Applications:Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

  • Unstained: unstained paraffin tissue microarray slide.
  • Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
  • H & E: Hematoxylin and Eosin stained tissue microarray slide.

Microarray Panel Display

 
Slide Label: US Biomax, Inc. Tissue Array
123456789
A Bra Eso Sto Liv Col Rec Lun Bla Hea
B Bra Eso Sto Liv Col Rec Lun Bla Hea
C Bra Eso Sto Liv Col Rec Lun Bla Hea
D Kid Thr Pan Ute Ski Bre Ova Pro Tes
E Kid Thr Pan Ute Ski Bre Ova Pro Tes
F Kid Thr Pan Ute Ski Bre Ova Pro Tes
Legend: Bla - Bladder, Bra - Brain, Bre - Breast, Col - Colon, Eso - Esophagus, Hea - Heart, Kid - Kidney, Liv - Liver, Lun - Lung, Ova - Ovary, Pan - Pancreas, Pro - Prostate, Rec - Rectum, Ski - Skin, Sto - Stomach, Tes - Testis, Thr - Thyroid, Ute - Uterine cervix

- Malignant tumor

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Grade Type †
A1 1 M 53 Brain Astrocytoma II Malignant
A2 2 M 62 Esophagus Squamous cell carcinoma III Malignant
A3 3 M 66 Stomach Adenocarcinoma I Malignant
A4 4 M 39 Liver Hepatocellular carcinoma with hemorrhage III Malignant
A5 5 M 37 Colon Adenocarcinoma III Malignant
A6 6 M 55 Rectum Adenocarcinoma III Malignant
A7 7 M 66 Lung Squamous cell carcinoma III Malignant
A8 8 F 76 Bladder Urothelial carcinoma II Malignant
A9 9 F 37 Heart Myxoma – Malignant
B1 10 M 25 Brain Astrocytoma I Malignant
B2 11 M 56 Esophagus Squamous cell carcinoma III Malignant
B3 12 M 65 Stomach Adenocarcinoma III Malignant
B4 13 F 55 Liver Hepatocellular carcinoma II Malignant
B5 14 M 58 Colon Adenocarcinoma II Malignant
B6 15 F 59 Rectum Adenocarcinoma III Malignant
B7 16 M 46 Lung Squamous cell carcinoma III Malignant
B8 17 M 38 Bladder Urothelial carcinoma I Malignant
B9 18 M 61 Heart A little myxoma – Malignant
C1 19 F 15 Brain Astrocytoma I Malignant
C2 20 F 72 Esophagus Squamous cell carcinoma II Malignant
C3 21 M 71 Stomach Adenocarcinoma II Malignant
C4 22 M 57 Liver Cholangiocellular carcinoma II Malignant
C5 23 F 78 Colon Adenocarcinoma II Malignant
C6 24 F 72 Rectum Adenocarcinoma II Malignant
C7 25 M 59 Lung Cartilage tissue – Malignant
C8 26 M 45 Bladder Urothelial carcinoma II Malignant
C9 27 F 47 Heart Myxoma – Malignant
D1 28 M 72 Kidney Clear cell carcinoma – Malignant
D2 29 M 68 Thyroid Papillary carcinoma – Malignant
D3 30 F 54 Pancreas Adenocarcinoma III Malignant
D4 31 F 62 Uterine cervix Squamous cell caricnoma III Malignant
D5 32 F 70 Skin Squamous cell caricnoma III Malignant
D6 33 F 72 Breast Nonspecific infiltrating duct carcinoma III Malignant
D7 34 F 40 Ovary Clear cell carcinoma – Malignant
D8 35 M 78 Prostate Adenocarcinoma I Malignant
D9 36 M 26 Testis B cell lymphoma – Malignant
E1 37 M 51 Kidney Clear cell carcinoma – Malignant
E2 38 F 24 Thyroid Papillary carcinoma – Malignant
E3 39 F 62 Pancreas Adenocarcinoma III Malignant
E4 40 F 30 Uterine cervix Squamous cell carcinoma III Malignant
E5 41 M 61 Skin Steatadenoma of auriculotemporal skin – Malignant
E6 42 F 45 Breast Nonspecific infiltrating duct carcinoma II Malignant
E7 43 F 50 Ovary Endometrioid carcinoma – Malignant
E8 44 M 73 Prostate Adenocarcinoma II Malignant
E9 45 M 59 Testis Seminoma – Malignant
F1 46 M 73 Kidney Clear cell carcinoma – Malignant
F2 47 F 55 Thyroid Papillary carcinoma – Malignant
F3 48 M 78 Pancreas Adenocarcinoma III Malignant
F4 49 F 30 Uterine cervix Squamous cell carcinoma III Malignant
F5 50 M 64 Skin Squamous cell carcinoma I Malignant
F6 51 F 65 Breast Nonspecific infiltrating duct carcinoma II Malignant
F7 52 F 40 Ovary Mucous cystadenocarcinoma III Malignant
F8 53 M 81 Prostate Transitional cell carcinoma III Malignant
F9 54 M 52 Testis Seminoma – Malignant


† For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.


Find overlapping cases with this tissue array:
© 2003 - 2011 US Biomax Inc., custsrv@biomax.us, Tel: (800) 935-1357 | Privacy Policy

Authorize.Net Seal Starfield Seal